patient with typical gcps or ph who have demonstrate gli3 mutation may be exclude from this study patients with phenotype and disorder with a high risk/benefit ratio such a late-onset neurodegenerative psychiatric and cancer-predisposition disorder will be exclude from participation similarly patients who be medically fragile or unable to tolerate travel to the nih cc will not routinely be eligible for participation probands who be adult and decisionally-impaired be ineligible if they do not have a legal guardian who have authority to sign a consent form on their behalf 